Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Progestogen-only injectable hormonal contraceptive use should be considered in analysis of studies addressing the loss of bone mineral density in HIV-positive women.

Beksinska ME, Smit JA, Ramkissoon A.

J Acquir Immune Defic Syndr. 2010 Aug;54(4):e5. doi: 10.1097/QAI.0b013e3181e49462. No abstract available.

PMID:
20611032
2.

Progestin-only contraception prevents bone loss in postpartum breastfeeding women.

Costa ML, Cecatti JG, Krupa FG, Rehder PM, Sousa MH, Costa-Paiva L.

Contraception. 2012 Apr;85(4):374-80. doi: 10.1016/j.contraception.2011.08.015.

PMID:
22036473
3.

Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.

Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR.

Maturitas. 2006 May 20;54(2):176-80.

PMID:
16332417
4.

Sex steroids and breast cancer prevention.

Spicer DV, Pike MC.

J Natl Cancer Inst Monogr. 1994;(16):139-47. Review.

PMID:
7999456
5.

Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.

Naessen T, Olsson SE, Gudmundson J.

Contraception. 1995 Jul;52(1):35-9.

PMID:
8521712
6.

[Awareness of the influence of progestin contraceptives on bone mineral content].

Jamin C.

Presse Med. 2002 Nov 23;31(37 Pt 1):1731-2. French. No abstract available.

PMID:
12489314
7.

Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.

Banks E, Berrington A, Casabonne D.

BJOG. 2001 Dec;108(12):1214-21. Review.

9.

Vaginal bleeding patterns in women using once-a-month injectable contraceptives.

Fraser IS.

Contraception. 1994 Apr;49(4):399-420. Review.

PMID:
8013222
10.

Long-acting methods of contraception.

Sarne DH.

N Engl J Med. 2006 Feb 9;354(6):645-6; author reply 645-6. No abstract available.

PMID:
16470954
11.

Effects of hormonal contraception on bone mineral density after 24 months of use.

Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.

Obstet Gynecol. 2004 May;103(5 Pt 1):899-906.

PMID:
15121563
12.

Injectable contraception.

Roy G.

Semin Reprod Med. 2010 Mar;28(2):126-32. doi: 10.1055/s-0030-1248137. Review.

PMID:
20352562
13.

Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.

Caird LE, Reid-Thomas V, Hannan WJ, Gow S, Glasier AF.

Clin Endocrinol (Oxf). 1994 Dec;41(6):739-45.

PMID:
7889609
14.

Long-acting hormonal contraception.

Bromham DR.

Ann N Y Acad Sci. 1997 Jun 17;816:432-9. Review.

PMID:
9238299
15.

Hormonal contraception: noncontraceptive benefits and medical contraindications.

Rager KM, Omar HA.

Adolesc Med Clin. 2005 Oct;16(3):539-51.

PMID:
16183538
16.

[Hormonal contraceptives].

Carlotti N.

Rev Prat. 2008 Jan 15;58(1):21-8. Review. French. Erratum in: Rev Prat. 2008 Jan 31;58(2):165.

PMID:
18326358
17.

Injectable long-acting contraceptives.

Kaunitz AM.

Clin Obstet Gynecol. 2001 Mar;44(1):73-91. Review. No abstract available.

PMID:
11219248
18.

Low-dose oral contraceptives and bone mineral density: an evidence-based analysis.

Kuohung W, Borgatta L, Stubblefield P.

Contraception. 2000 Feb;61(2):77-82. Review.

PMID:
10802271
19.

Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.

van Leeuwen FE.

Acta Endocrinol (Copenh). 1991;125 Suppl 1:13-26. Review.

PMID:
1801500
20.

The contraceptive vaginal ring.

Edwardson J, Jamshidi R.

Semin Reprod Med. 2010 Mar;28(2):133-9. doi: 10.1055/s-0030-1248138. Review.

PMID:
20352563

Supplemental Content

Support Center